Capital Southwest Supports Gauge Capital’s Majority Recapitalization of American Nuts
Apr 24, 2018 20:01 pm UTC| Business
DALLAS, April 24, 2018 -- Capital Southwest Corporation (“Capital Southwest”) (Nasdaq:CSWC) announced today that it supported the recent majority recapitalization of American Nuts, LLC (“American Nuts”) by Gauge Capital...
Covenant Transportation Group Announces First Quarter Financial and Operating Results
Apr 24, 2018 20:01 pm UTC| Business
CHATTANOOGA, Tenn., April 24, 2018 -- Covenant Transportation Group, Inc. (NASDAQ:CVTI) (“CTG”) announced today financial and operating results for the first quarter ended March 31, 2018. Highlights for the quarter...
Apr 24, 2018 20:01 pm UTC| Business
MIDLAND, Texas, April 24, 2018 -- Viper Energy Partners LP (NASDAQ:VNOM) (“Viper”), a subsidiary of Diamondback Energy, Inc. (NASDAQ:FANG) (“Diamondback”), announced that they plan to release first quarter 2018...
COFFEE HOLDING JOINT VENTURE ACQUIRES STEEP N BREW COFFEE COMPANY
Apr 24, 2018 20:01 pm UTC| Business
STATEN ISLAND, N.Y., April 24, 2018 -- Coffee Holding Co., Inc. (“Coffee Holding” or the “Company”) (Nasdaq: JVA) announces the acquisition of substantially all of the assets of Steep N Brew Coffee Company...
Konica Minolta AccurioPress Line-up Gets a Productivity Boost with Newest EFI Fiery Upgrade
Apr 24, 2018 20:01 pm UTC| Business
FREMONT, Calif., April 24, 2018 -- EFI™ Fiery® FS300 Pro – the newest, most-advanced Fiery digital front end (DFE) platform to date – is now available for the Konica Minolta® AccurioPress™ line of digital presses...
Aspen Group, Inc. Announces Early Retirement of $10 million Credit Facility
Apr 24, 2018 20:01 pm UTC| Business
NEW YORK, April 24, 2018 -- Aspen Group, Inc. (Nasdaq:ASPU), a post-secondary education company, today announced the early retirement of its $10 million senior secured term loan with Runway Growth Credit Fund, of which...
Apr 24, 2018 20:01 pm UTC| Business
– A mean increase in CHOP-INTEND of 17.3 was observed at three months post gene therapy in SMA Type 1 U.S. pivotal trial – – All patients in the therapeutic dose cohort in the Phase 1 trial were alive and event-free at...